DrugPatentWatch Database Preview
CICLESONIDE - Generic Drug Details
» See Plans and Pricing
What are the generic sources for ciclesonide and what is the scope of patent protection?
Ciclesonide
is the generic ingredient in three branded drugs marketed by Covis Pharma Bv and is included in three NDAs. There are three patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.Ciclesonide has one hundred and seven patent family members in thirty-six countries.
There are seven drug master file entries for ciclesonide. One supplier is listed for this compound.
Summary for CICLESONIDE
International Patents: | 107 |
US Patents: | 3 |
Tradenames: | 3 |
Applicants: | 1 |
NDAs: | 3 |
Drug Master File Entries: | 7 |
Suppliers / Packagers: | 1 |
Bulk Api Vendors: | 46 |
Clinical Trials: | 72 |
Patent Applications: | 4,555 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price trends for CICLESONIDE |
DailyMed Link: | CICLESONIDE at DailyMed |
Recent Clinical Trials for CICLESONIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
McGill University Health Centre/Research Institute of the McGill University Health Centre | Phase 2/Phase 3 |
Covis Pharma S.à.r.l. | Phase 3 |
Centrallasarettet Västerås | Phase 2 |
Paragraph IV (Patent) Challenges for CICLESONIDE
Tradename | Dosage | Ingredient | NDA | Submissiondate |
---|---|---|---|---|
OMNARIS | SPRAY, METERED;NASAL | ciclesonide | 022004 | 2012-02-13 |
US Patents and Regulatory Information for CICLESONIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Covis Pharma Bv | ZETONNA | ciclesonide | AEROSOL, METERED;NASAL | 202129-001 | Jan 20, 2012 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
Covis Pharma Bv | OMNARIS | ciclesonide | SPRAY, METERED;NASAL | 022004-001 | Oct 20, 2006 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
Covis Pharma Bv | ALVESCO | ciclesonide | AEROSOL, METERED;INHALATION | 021658-002 | Jan 10, 2008 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
Covis Pharma Bv | ALVESCO | ciclesonide | AEROSOL, METERED;INHALATION | 021658-003 | Jan 10, 2008 | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
Covis Pharma Bv | OMNARIS | ciclesonide | SPRAY, METERED;NASAL | 022004-001 | Oct 20, 2006 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for CICLESONIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Covis Pharma Bv | ALVESCO | ciclesonide | AEROSOL, METERED;INHALATION | 021658-002 | Jan 10, 2008 | Start Trial | Start Trial |
Covis Pharma Bv | ALVESCO | ciclesonide | AEROSOL, METERED;INHALATION | 021658-003 | Jan 10, 2008 | Start Trial | Start Trial |
Covis Pharma Bv | ZETONNA | ciclesonide | AEROSOL, METERED;NASAL | 202129-001 | Jan 20, 2012 | Start Trial | Start Trial |
Covis Pharma Bv | ALVESCO | ciclesonide | AEROSOL, METERED;INHALATION | 021658-002 | Jan 10, 2008 | Start Trial | Start Trial |
Covis Pharma Bv | ZETONNA | ciclesonide | AEROSOL, METERED;NASAL | 202129-001 | Jan 20, 2012 | Start Trial | Start Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for CICLESONIDE
Country | Patent Number | Estimated Expiration |
---|---|---|
Serbia | 50345 | Start Trial |
Slovenia | 1670482 | Start Trial |
Israel | 148725 | Start Trial |
New Zealand | 518299 | Start Trial |
Hong Kong | 1149719 | Start Trial |
>Country | >Patent Number | >Estimated Expiration |